| Literature DB >> 33086748 |
Tinus Schynkel1, Matthew A Szaniawski2, Adam M Spivak3, Alberto Bosque4, Vicente Planelles2, Linos Vandekerckhove1, Wim Trypsteen1.
Abstract
Interferons play a critical role in the innate immune response against a variety of pathogens, such as HIV-1. Recent studies have shown that long non-coding genes are part of a reciprocal feedforward/feedback relationship with interferon expression. They presumably contribute to the cell type specificity of the interferon response, such as the phenotypic and functional transition of macrophages throughout the immune response. However, no comprehensive understanding exists today about the IFN-lncRNA interplay in macrophages, also a sanctuary for latent HIV-1. Therefore, we completed a poly-A+ RNAseq analysis on monocyte-derived macrophages (MDMs) treated with members of all three types of IFNs (IFN-α, IFN-ε, IFN-γ or IFN-λ) and on macrophages infected with HIV-1, revealing an extensive non-coding IFN and/or HIV-1 response. Moreover, co-expression correlation with mRNAs was used to identify important (long) non-coding hub genes within IFN- or HIV-1-associated gene clusters. This study identified and prioritized IFN related hub lncRNAs for further functional validation.Entities:
Keywords: Human Immunodeficiency Virus (HIV); RNA-seq; interferon; long non-coding RNA; macrophage
Mesh:
Substances:
Year: 2020 PMID: 33086748 PMCID: PMC7589721 DOI: 10.3390/ijms21207741
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The differential expression profile of macrophages stimulated with IFN-α, IFN-ε, IFN-γ or IFN-λ or infected with HIV-1. (A) (Left) The number of differentially expressed protein coding genes (Padj < 0.05; log2 fold change > 1 or < −1). (Right) The differentially expressed non-coding genes. (B) Venn diagram showing the number of overlapping differentially expressed non-coding genes in the interferon stimulated conditions. (C) Heatmap including the top 25 differentially expressed non-coding genes for every condition were included. Color scale indicates the extend of the log2 fold change for each sample compared to the mean expression of the non-treated control (triplicate). Blue indicates downregulation (log2 FC < 0), red indicates upregulation (log2 FC < 0).
Figure 2qPCR validation of three mRNAs and five non-coding genes. The RNA from the three replicates for every condition was pooled and the log2 fold change was determined compared to the untreated condition (n = 2). The data were normalized using three selected reference genes.
Figure 3Weighted gene co-expression network analysis (WGCNA). (A) Hierarchical dendrogram of an unsigned, single-block gene co-expression network created based on bi-weight mid-correlation between gene expression over all samples. (B) Module–trait heatmap displaying the correlation between the eigengene of a module and the trait status (IFN-α, IFN-ε, IFN-γ, IFN-λ or HIV-1). Red indicates a positive correlation, while green indicates a negative correlation. (C) Scatterplot showing for each individual gene within the brown module the gene significance for IFN-α stimulation vs. its module membership. Genes that are considered hub genes are depicted in red.
Significantly enriched Gene Ontology Biological Process (GO_BP) terms for each module of the WGCNA. Modules not mentioned have no significant enriched term based on the Bonferroni-adjusted p-value.
| Module | ID | Biological Process | Number of Genes (%) | Padj |
|---|---|---|---|---|
| Black | GO:0030198 | extracellular matrix organization | 27 (6.8) | 1.32 × 10−4 |
| Black | GO:0006954 | inflammatory response | 39 (4.8) | 1.06 × 10−3 |
| Black | GO:0030335 | positive regulation of cell migration | 32 (5.2) | 3.15 × 10−3 |
| Black | GO:0097529 | myeloid leukocyte migration | 18 (7.7) | 5.02 × 10−3 |
| Black | GO:0043062 | extracellular structure organization | 28 (5.5) | 5.61 × 10−3 |
| Blue | GO:0035966 | response to topologically incorrect protein | 66 (32.2) | 4.91 × 10−7 |
| Blue | GO:0070925 | organelle assembly | 205 (21.9) | 6.09 × 10−7 |
| Blue | GO:0034976 | response to endoplasmic reticulum stress | 82 (27.9) | 7.73 × 10−6 |
| Blue | GO:0007049 | cell cycle | 373 (18.9) | 1.17 × 10−5 |
| Blue | GO:0006974 | cellular response to DNA damage stimulus | 189 (21.4) | 3.19 × 10−5 |
| Brown | GO:0016032 | viral process | 213 (25.0) | 2.61 × 10−15 |
| Brown | GO:0044403 | symbiotic process | 222 (24.4) | 9.79 × 10−15 |
| Brown | GO:0044419 | interspecies interaction between organisms | 229 (23.9) | 4.11 × 10−14 |
| Brown | GO:0034341 | response to interferon-gamma | 69 (33.2) | 6.15 × 10−9 |
| Brown | GO:0045087 | innate immune response | 224 (21.4) | 1.93 × 10−8 |
| Cyan | GO:0098740 | multi organism cell adhesion | 2 (100) | 2.98 × 10−2 |
| Midnightblue | GO:0003009 | skeletal muscle contraction | 4 (8.3) | 3.46 × 10−2 |
| Pink | GO:0006119 | oxidative phosphorylation | 24 (15.7) | 6.17 × 10−15 |
| Pink | GO:0015985 | energy coupled proton transport, down electrochemical gradient | 24 (15.4) | 9.85 × 10−15 |
| Pink | GO:0015986 | ATP synthesis coupled proton transport | 24 (15.4) | 9.85 × 10−15 |
| Pink | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 25 (13.0) | 1.31 × 10−13 |
| Pink | GO:0009145 | purine nucleoside triphosphate biosynthetic process | 25 (12.9) | 1.49 × 10−13 |
| Tan | GO:0050859 | negative regulation of B cell receptor signaling pathway | 3 (37.5) | 2.22 × 10−2 |
| Turquoise | GO:0007049 | cell cycle | 509 (25.8) | 7.43 × 10−23 |
| Turquoise | GO:0022402 | cell cycle process | 438 (26.8) | 1.11 × 10−22 |
| Turquoise | GO:0000278 | mitotic cell cycle | 316 (29.2) | 1.58 × 10−21 |
| Turquoise | GO:1903047 | mitotic cell cycle process | 316 (29.2) | 1.58 × 10−21 |
| Turquoise | GO:0140014 | mitotic nuclear division | 316 (29.2) | 1.58 × 10−21 |
| Yellow | GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 19 (19.0) | 2.99 × 10−3 |
| Yellow | GO:0042773 | ATP synthesis coupled electron transport | 19 (18.8) | 3.51 × 10−3 |
| Yellow | GO:0090407 | organophosphate biosynthetic process | 68 (9.1) | 8.61 × 10−3 |
| Yellow | GO:0022900 | electron transport chain | 27 (13.4) | 2.00 × 10−2 |
| Yellow | GO:0019637 | organophosphate metabolic process | 95 (79.2) | 3.04 × 10−2 |
Significantly enriched pathways (KEGG/REACTOME) for each module of the WGCNA. Modules not mentioned have no significant enriched term based on the Bonferroni-adjusted p-value.
| Module | ID | Biological Process | Source | Number of Genes (%) | Padj |
|---|---|---|---|---|---|
| Blue | 1269649 | Gene expression | REACTOME | 372 (20.2) | 1.63 × 10−8 |
| Blue | 1270038 | Regulation of cholesterol biosynthesis by SREBP | REACTOME | 25 (45.5) | 1.01 × 10−4 |
| Blue | 1270039 | Activation of gene expression by SREBF | REACTOME | 21 (50.0) | 1.51 × 10−4 |
| Blue | 1270037 | Cholesterol biosynthesis | REACTOME | 15 (62.5) | 2.26 × 10−4 |
| Blue | 1268838 | Organelle biogenesis and maintenance | REACTOME | 86 (25.2) | 4.61 × 10−4 |
| Black | 1270244 | Extracellular matrix organization | REACTOME | 24 (8.1) | 1.85 × 10−5 |
| Black | 1470923 | Interleukin-4 and 13 signaling | REACTOME | 12 (10.2) | 5.05 × 10−3 |
| Black | 1270254 | Non-integrin membrane-ECM interactions | REACTOME | 7 (15.2) | 4.68 × 10−2 |
| Brown | 1269311 | Interferon signaling | REACTOME | 65 (32.2) | 2.24 × 10−7 |
| Brown | 377873 | Herpes simplex infection | KEGG | 57 (30.8) | 1.85 × 10−5 |
| Brown | 1269171 | Adaptive immune system | REACTOME | 175 (21.2) | 9.65 × 10−5 |
| Brown | 1269312 | Interferon alpha/beta signaling | REACTOME | 28 (40.6) | 2.02 × 10−4 |
| Brown | 1269314 | Interferon gamma signaling | REACTOME | 34 (36.2) | 2.63 × 10−4 |
| Pink | 82942 | Oxidative phosphorylation | KEGG | 22 (16.5) | 8.76 × 10−14 |
| Pink | 1270121 | TCA cycle and respitory electron transport | REACTOME | 24 (14.0) | 1.64 × 10−13 |
| Pink | 83098 | Parkinson’s disease | KEGG | 21 (14.8) | 4.69 × 10−12 |
| Pink | 1270127 | Respiratory electron transport | REACTOME | 20 (15.9) | 5.28 × 10−12 |
| Pink | 83097 | Alzheimer’s disease | KEGG | 21 (12.3) | 2.06 × 10−10 |
| Tan | 1427857 | Regulation of TLR by endogeneous ligand | REACTOME | 3 (18.3) | 3.21 × 10−2 |
| Turquoise | 1269741 | Cell cycle | REACTOME | 215 (34.5) | 7.99 × 10−21 |
| Turquoise | 1269763 | Cell cycle, mitotic | REACTOME | 183 (35.4) | 8.48 × 10−19 |
| Turquoise | 1427846 | rRNA processing in the nucleus and cytosol | REACTOME | 87 (45.1) | 4.25 × 10−15 |
| Turquoise | 1383086 | Major pathway of rRNA processing | REACTOME | 83 (45.9) | 4.25 × 10−15 |
| Turquoise | 1269649 | Gene expression | REACTOME | 468 (25.4) | 9.78 × 10−15 |
| Yellow | 1270128 | Respiratory electron transport | REACTOME | 18 (17.5) | 1.42 × 10−2 |
| Yellow | 82942 | Oxidative phosphorylation | KEGG | 20 (15.0) | 4.66 × 10−2 |
Figure 4Networks displaying the predicted interactions between the differentially expressed (hub) genes of the brown module for: (A) IFN-α stimulation; and (B) IFN-ε stimulation. Three interaction types are depicted: (1) protein–protein interactions determined with the STRING webtool [24]; (2) Poly-A+ ncRNA–mRNA interactions predicted by LncTAR based on the binding free energy between the mRNA and the lncRNA sequences [25]; and (3) ncRNA–mRNA interactions based on genomic co-localization [26].
Figure 5Network displaying the predicted interactions between the genes of the brown module that are differentially expressed upon HIV-1 infection. Three interaction types are depicted: (1) protein–protein interactions determined with the STRING webtool [24]; (2) Poly-A+ ncRNA–mRNA interactions predicted by LncTAR based on the binding free energy between the mRNA and the lncRNA sequences [25]; and (3) ncRNA–mRNA interactions based on genomic co-localization [26].